Pre-exposure prophylaxis with tixagevimab/cilgavimab in patients with chronic lymphocytic leukaemia treated with targeted agents

Affiliations

• ¹ Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
• ² Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padova, Italy.
• ³ Design and Analysis of Clinical Trials Unit, Scientific Directorate, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
• ⁴ National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.
• ⁵ Laboratory of Virology, National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome, Italy.
• ⁶ North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.